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A fungus among us
The opportunistic pathogen Candida albicans, which causes 
oropharyngeal candidiasis, is strongly associated with 
HIV/AIDS, implicating the adaptive immune response in 
its control. In the blood, the T cells that are reactive to this 
pathogen are largely T helper type 17 (Th17) cells. Whereas 
humans are exposed to Candida early in life, resulting in a 
strong adaptive Th17 response, mice are naive to the fungus, 
allowing study of the innate immune response in an acute 
model of oral candidiasis in these animals. Conti and col-
leagues demonstrated that an intact T-cell receptor is required 
for innate responses, IL-17 is induced within 24 hours, and 
clearance is dependent on IL-17R signaling. Furthermore, γδ 
T cells and tissue-resident natural Th17 (nTh17) cells, a popu-
lation of CD3+CD4+CD44+TCRβ+CCR6+cells, appear to be 
the primary sources of IL-17 and are immediate mediators 
of protection against oral mucosal Candida infection. This 
report is the first to document this poorly characterized cell 
type in the oral mucosa and suggests that nTh17 cells serve 
as sentinels to mount a response against oral pathogens. 
(J Exp Med 211:2075–84, 2014) Selected by N. Ward
Second hit by the sun
In tuberous sclerosis complex (TSC), patients harbor a germ-
line mutation in one allele of a tumor suppressor gene (TSC1 
or TSC2) and then gain a somatic mutation in the second 
allele, leading to development of multiple tumors. Tyburczy 
and colleagues recently identified germ-line and second-
hit mutations in TSC skin lesions from 22 TSC patients. The 
somatic second-hit mutations that occurred specifically in 
dermal fibroblasts from TSC facial angiofibromas were of the 
form CC>TT, which is a product of sunlight-induced DNA 
damage caused by the formation of cyclobutane pyrimidine 
dimers at adjacent pyrimidines in response to UVR. These 
findings suggest that simple sun-protective measures may 
decrease the number and/or severity of facial angiofibro-
mas, which are common in TSC patients. (Hum Mol Genet 
23:2023–9, 2014) Selected by T. Darling
Overdiagnosis or adequate diagnosis?
The observation that good outcomes are often achieved for 
patients identified at the earliest stages of a disease has led 
to the overarching belief that detection of cancer at the ear-
liest stages is critical; however, overdiagnosis may lead to 
overtreatment, which offers the potential for dangerous side 
effects and associated morbidity and mortality. Following 
a US National Cancer Institute multidisciplinary brain-
storming session in March 2012, Esserman and colleagues 
authored a Personal View statement to address overdiagnosis 
and overtreatment. The working group’s recommendation 
included a request to develop new terminology to replace 
the word “cancer” in diagnoses when appropriate, to create 
observational registries for indolent lesions of epithelial 
origin with low or uncertain risk of progression to cancer, 
and to mitigate overdiagnosis by testing strategies to lower 
detection of insignificant lesions. These authors describe 
a different approach to cancer screening and treatment in 
order to maximize the benefit to the patient and the popula-
tion. (Lancet Oncol 15:e234–42, 2014) Selected by T. Nijsten
JAK of all trades
The T cell–mediated autoimmune disease alopecia areata 
(AA) is characterized by hair loss accompanied by infiltra-
tion of T cells around the hair follicle bulb. Development 
of effective targeted therapies has been hindered by a lack 
of understanding of the involved T-cell inflammatory path-
ways. Recently, in a mouse model of AA pathogenesis, Xing 
and colleagues found that CD8+NKG2D+ T cells are neces-
sary and sufficient for induction of AA via T cell–mediated 
transfer of disease and that these cells function as cytolytic 
effectors to induce attack of the hair follicle. Interestingly, 
blockade of IFN-γ, IL-2, or IL-15R prevented disease devel-
opment and reduced accumulation of CD8+NKG2D+ T 
cells in these animals. Treatment of three patients with an 
inhibitor (ruxolitinib) of Janus kinase (JAK)-1/2, which are 
downstream effectors of IFN-γ, resulted in almost com-
plete hair regrowth. These results support the potential use 
of JAK inhibition to treat AA. (Nat Med 20:1043–9, 2014) 
Selected by B. Gilchrest
Triple threat
In a recent report, Oláh and colleagues examined the effects 
of (–)-cannabidiol (CBD), the major nonpsychotropic phyto-
cannabinoid of Cannabis sativa, on the human sebaceous 
gland using human immortalized sebocytes and human 
skin organ culture. This agent, which is already utilized in 
clinical practice for other ailments, induced a triple threat 
of antiacne actions. CBD normalized the pathologically 
elevated lipogenesis induced by acne agents, suppressed 
cell proliferation of sebocytes, and exerted universal anti-
inflammatory effects, and confirmation of these findings 
in a human skin organ culture underscored the possibility 
that CBD may be useful in treating human patients. Taken 
together, these results suggest that the phytocannabinoid 
CBD is a universal antiacne agent. Many human studies 
have already chronicled the safety of this compound, indi-
cating its potential as an effective and well-tolerated novel 
strategy for treating acne vulgaris, the most common human 
skin disease. This finding is particularly important because 
the most effective currently available antiacne agent, 
isotretinoin, is plagued with numerous serious side effects. 
(J Clin Invest 124:3713–24, 2014) Selected by L. GoldsmithJournal of Investigative Dermatology (2014) 134, 2858. doi:10.1038/ jid.2014.433
